Advertisement
Screener

Decoy Therapeutics Inc. (DCOY) Form D

Decoy Therapeutics Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2024-12-27: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale Yet to occur; Total offering amount $10,000,000.
  • 2014-08-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2014-07-23; Total offering amount $22,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2024-12-27Rule 506(b)EquityYet to occur$10,000,000$0$10,000,0001
2014-08-06Rule 506(b)Equity2014-07-23$22,000,000$16,224,982$5,775,01820

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexentis Technologies Inc. (NXTS)$0.002B
ORAGENICS INC (OGEN)United States$0.002B
JUPITER NEUROSCIENCES, INC. (JUNS)United States$0.002B-0.02
BioXcel Therapeutics, Inc. (BTAI)United States$0.002B
ZyVersa Therapeutics, Inc. (ZVSA)United States$0.002B
Matinas BioPharma Holdings, Inc. (MTNB)United States$0.003B
Petros Pharmaceuticals, Inc. (PTPI)United States$0.003B
GeoVax Labs, Inc. (GOVX)United States$0.003B-0.45
Protagenic Therapeutics, Inc.\new (PTIX)United States$0.001B
Silo Pharma, Inc. (SILO)United States$0.003B-1.57